A pill that halves lung cancer death rates
New Jersey: A pill used for lung cancer can reduce the risk of the disease coming back and dying within five years, a study has found. New England Journal of Medicine In a study published in , scientists tested 682 people over three years. 339 people were given osimertinib and 343 people were given a…